Medicare Enrolled
Dr. Clayton Hinshaw, MD
Procedural Dermatology Physician · Simi Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hinshaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hinshaw?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hinshaw
Dr. Clayton Hinshaw is a procedural dermatology physician in Simi Valley, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hinshaw performed 7,093 Medicare services across 3,064 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hinshaw received a total of $6,648 from 32 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hinshaw is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in CA
$6,648 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,093
Medicare services
Top 22% in CA for procedural dermatology physician
3,064
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~355 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,745 | $6 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,226 | $67 | $105 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
781 | $61 | $110 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
759 | $42 | $95 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
454 | $80 | $135 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
202 | $90 | $150 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
180 | $45 | $75 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
134 | $262 | $426 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
92 | $1 | $18 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
83 | $107 | $259 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
82 | $73 | $145 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
64 | $142 | $345 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
38 | $119 | $316 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
33 | $122 | $434 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
31 | $40 | $76 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
30 | $116 | $376 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
29 | $129 | $303 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 28 | $271 | $393 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
23 | $255 | $372 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
23 | $38 | $100 |
| Skin cancer removal, face or mouth area, 0.6-1.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters. |
19 | $117 | $316 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
13 | $10 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $45 | $75 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
11 | $197 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,648
Total received (2018-2024)
Avg $950/year across 7 years
Top 30% in CA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,471 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$863
2023
$1,572
2022
$728
2021
$698
2020
$533
2019
$1,195
2018
$1,058
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$216
SUN PHARMACEUTICAL INDUSTRIES INC.
$137
PFIZER INC.
$134
GENZYME CORPORATION
$133
ABBVIE INC.
$60
Galderma Laboratories, L.P.
$38
E.R. Squibb & Sons, L.L.C.
$38
Lilly USA, LLC
$34
Amgen Inc.
$33
Regeneron Healthcare Solutions, Inc.
$23
MAYNE PHARMA COMMERCIAL LLC
$17
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$879
Novartis Pharmaceuticals Corporation
$660
GENZYME CORPORATION
$539
Janssen Biotech, Inc.
$526
PFIZER INC.
$496
LEO Pharma Inc.
$467
Regeneron Healthcare Solutions, Inc.
$422
Journey Medical Corporation
$312
Amgen Inc.
$308
SUN PHARMACEUTICAL INDUSTRIES INC.
$286
Lilly USA, LLC
$257
Ortho Dermatologics, a division of Bausch Health US, LLC
$203
Incyte Corporation
$202
Galderma Laboratories, L.P.
$173
PruGen, Inc. Pharmaceuticals
$132
MAYNE PHARMA COMMERCIAL LLC
$90
E.R. Squibb & Sons, L.L.C.
$86
Mayne Pharma Inc.
$63
Pierre Fabre Pharmaceuticals, Inc.
$62
Genentech USA, Inc.
$61
MAYNE PHARMA INC.
$60
ABBVIE INC.
$60
UCB, Inc.
$59
Arcutis Biotherapeutics, Inc.
$54
Paratek Pharmaceuticals, Inc.
$44
Aclaris Therapeutics, Inc.
$27
Celgene Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
EPI Health, LLC
$22
DUSA Pharmaceuticals, Inc.
$22
Almirall LLC
$18
TARO PHARMACEUTICALS USA, INC.
$12
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · Absorica LD · BLU-U · BOTOX · CIBINQO · COSENTYX · Ceracade · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · Exelderm · FINACEA · HYLATOPIC EMOLLIENT · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · LEVULAN KERASTICK · LIBTAYO · LITFULO · NUZYRA · ODOMZO · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · REMICADE · RHOFADE · RINVOQ · SOOLANTRA · SPEVIGO · Sitavig · Sotyktu · TALTZ · TREMFYA · TargaDox · ULTRAVATE · Winlevi · Xolegel
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Procedural dermatology physicians within 10 mi
15
Per 100K population
1.8
County median income
$107,327
Nearest hospital
ADVENTIST HEALTH SIMI VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hinshaw is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hinshaw experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Hinshaw performed 2,745 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hinshaw receive payments from pharmaceutical companies?
Yes. Dr. Hinshaw received a total of $6,648 from 32 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hinshaw's costs compare to other procedural dermatology physicians in Simi Valley?
Dr. Hinshaw's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hinshaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Simi Valley
Browse procedural dermatology physicians in Simi Valley ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in CA
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in CA
Which CA procedural dermatology physicians receive the most from drug and device companies.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology